NCT03788252View on ClinicalTrials.gov

Role of AST120 for Sarcopenia Prevention in Pre-dialysis Chronic Kidney Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

November 23, 2018

Primary Completion Date

July 14, 2020

Study Completion Date

July 14, 2020

Conditions
Chronic Kidney Diseases
Interventions
DRUG

Renamezin

7 capsules once, three times a day, for 48 weeks

Trial Locations (1)

39295

CHA Gumi Medical Center, Gumi

Sponsors
All Listed Sponsors
lead

Gumi Cha Medical Center

OTHER